Charles S. Hrushka
Nessuna posizione attualmente
Profilo
Charles S.
Hrushka served as the Managing Director at ScheBoBiotech USA, Inc. from 2001 to 2004.
He was the President & Chief Operating Officer at Burren Pharmaceuticals, Inc. from 2004 to 2005.
He also worked as the Vice President-Marketing at Sucampo Pharmaceuticals, Inc. and as the Vice President-Sales & Marketing at Pernix Therapeutics Holdings, Inc. Hrushka holds an MBA from Georgia State University and an undergraduate degree from the University of Lynchburg.
Precedenti posizioni note di Charles S. Hrushka
| Società | Posizione | Fine |
|---|---|---|
| PERNIX THERAPEUTICS HOLDINGS INC | Vendite & Marketing | 18/01/2013 |
| Burren Pharmaceuticals, Inc. | Presidente | 01/12/2005 |
| ScheBoBiotech USA, Inc. | Corporate Officer/Principal | 01/09/2004 |
| SUCAMPO PHARMACEUTICALS, INC. | Vendite & Marketing | - |
Formazione di Charles S. Hrushka
| Georgia State University | Masters Business Admin |
| University of Lynchburg | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Sucampo Pharmaceuticals, Inc.
 Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |
| Burren Pharmaceuticals, Inc. | |
| ScheBoBiotech USA, Inc. | |
Pernix Therapeutics Holdings, Inc.
 Pernix Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. It distributes products through the following brands: Treximet, Silenor, and Zohydro ER with BeadTek. The company was founded in 1996 and is headquartered in Morristown, NJ. | Health Technology |
- Borsa valori
- Insiders
- Charles S. Hrushka
